A citation-based method for searching scientific literature

P Lind, K Larsson, J Spira, M Sydow-Bäckman, A Almstedt, E Gray, H Sandberg. Eur J Biochem 1995
Times Cited: 99







List of co-cited articles
897 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Structure of human factor VIII.
G A Vehar, B Keyt, D Eaton, H Rodriguez, D P O'Brien, F Rotblat, H Oppermann, R Keck, W I Wood, R N Harkins,[...]. Nature 1984
767
35

A large region (approximately equal to 95 kDa) of human factor VIII is dispensable for in vitro procoagulant activity.
J J Toole, D D Pittman, E C Orr, P Murtha, L C Wasley, R J Kaufman. Proc Natl Acad Sci U S A 1986
279
31

Biochemical, immunological, and in vivo functional characterization of B-domain-deleted factor VIII.
D D Pittman, E M Alderman, K N Tomkinson, J H Wang, A R Giles, R J Kaufman. Blood 1993
214
28

Molecular cloning of a cDNA encoding human antihaemophilic factor.
J J Toole, J L Knopf, J M Wozney, L A Sultzman, J L Buecker, D D Pittman, R J Kaufman, E Brown, C Shoemaker, E C Orr. Nature 1984
820
25


Long-term safety and efficacy of factor IX gene therapy in hemophilia B.
Amit C Nathwani, Ulreke M Reiss, Edward G D Tuddenham, Cecilia Rosales, Pratima Chowdary, Jenny McIntosh, Marco Della Peruta, Elsa Lheriteau, Nishal Patel, Deepak Raj,[...]. N Engl J Med 2014
744
19

Characterization of the human factor VIII gene.
J Gitschier, W I Wood, T M Goralka, K L Wion, E Y Chen, D H Eaton, G A Vehar, D J Capon, R M Lawn. Nature 1984
800
18

Structural and functional characteristics of the B-domain-deleted recombinant factor VIII protein, r-VIII SQ.
H Sandberg, A Almstedt, J Brandt, E Gray, L Holmquist, U Oswaldsson, S Sebring, M Mikaelsson. Thromb Haemost 2001
64
26

Adenovirus-associated virus vector-mediated gene transfer in hemophilia B.
Amit C Nathwani, Edward G D Tuddenham, Savita Rangarajan, Cecilia Rosales, Jenny McIntosh, David C Linch, Pratima Chowdary, Anne Riddell, Arnulfo Jaquilmac Pie, Chris Harrington,[...]. N Engl J Med 2011
17

Construction and characterization of an active factor VIII variant lacking the central one-third of the molecule.
D L Eaton, W I Wood, D Eaton, P E Hass, P Hollingshead, K Wion, J Mather, R M Lawn, G A Vehar, C Gorman. Biochemistry 1986
260
16

Isolation and characterization of human factor VIII: molecular forms in commercial factor VIII concentrate, cryoprecipitate, and plasma.
L O Andersson, N Forsman, K Huang, K Larsen, A Lundin, B Pavlu, H Sandberg, K Sewerin, J Smart. Proc Natl Acad Sci U S A 1986
144
15

Role of the B domain for factor VIII and factor V expression and function.
D D Pittman, K A Marquette, R J Kaufman. Blood 1994
62
24


Therapeutic levels of FVIII following a single peripheral vein administration of rAAV vector encoding a novel human factor VIII variant.
Jenny McIntosh, Peter J Lenting, Cecilia Rosales, Doyoung Lee, Samira Rabbanian, Deepak Raj, Nishil Patel, Edward G D Tuddenham, Olivier D Christophe, John H McVey,[...]. Blood 2013
177
15


Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response.
Catherine S Manno, Glenn F Pierce, Valder R Arruda, Bertil Glader, Margaret Ragni, John J Rasko, Margareth C Ozelo, Keith Hoots, Philip Blatt, Barbara Konkle,[...]. Nat Med 2006
14

Expression of active human factor VIII from recombinant DNA clones.
W I Wood, D J Capon, C C Simonsen, D L Eaton, J Gitschier, B Keyt, P H Seeburg, D H Smith, P Hollingshead, K L Wion,[...]. Nature 1984
610
13

High level expression of recombinant porcine coagulation factor VIII.
Christopher B Doering, John F Healey, Ernest T Parker, Rachel T Barrow, Pete Lollar. J Biol Chem 2002
81
16

AAV liver expression of FIX-Padua prevents and eradicates FIX inhibitor without increasing thrombogenicity in hemophilia B dogs and mice.
Julie M Crudele, Jonathan D Finn, Joshua I Siner, Nicholas B Martin, Glenn P Niemeyer, Shangzhen Zhou, Federico Mingozzi, Clinton D Lothrop, Valder R Arruda. Blood 2015
97
13

X-linked thrombophilia with a mutant factor IX (factor IX Padua).
Paolo Simioni, Daniela Tormene, Giulio Tognin, Sabrina Gavasso, Cristiana Bulato, Nicholas P Iacobelli, Jonathan D Finn, Luca Spiezia, Claudia Radu, Valder R Arruda. N Engl J Med 2009
193
12

Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant.
Lindsey A George, Spencer K Sullivan, Adam Giermasz, John E J Rasko, Benjamin J Samelson-Jones, Jonathan Ducore, Adam Cuker, Lisa M Sullivan, Suvankar Majumdar, Jerome Teitel,[...]. N Engl J Med 2017
359
12

AAV5-Factor VIII Gene Transfer in Severe Hemophilia A.
Savita Rangarajan, Liron Walsh, Will Lester, David Perry, Bella Madan, Michael Laffan, Hua Yu, Christian Vettermann, Glenn F Pierce, Wing Y Wong,[...]. N Engl J Med 2017
348
12

Biosynthesis, assembly and secretion of coagulation factor VIII.
R J Kaufman, S W Pipe, L Tagliavacca, M Swaroop, M Moussalli. Blood Coagul Fibrinolysis 1997
65
16

Effect of von Willebrand factor coexpression on the synthesis and secretion of factor VIII in Chinese hamster ovary cells.
R J Kaufman, L C Wasley, M V Davies, R J Wise, D I Israel, A J Dorner. Mol Cell Biol 1989
152
11


Expression of the blood-clotting factor-VIII cDNA is repressed by a transcriptional silencer located in its coding region.
R C Hoeben, F J Fallaux, S J Cramer, D J van den Wollenberg, H van Ormondt, E Briët, A J van der Eb. Blood 1995
72
15


Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A.
L Bi, A M Lawler, S E Antonarakis, K A High, J D Gearhart, H H Kazazian. Nat Genet 1995
491
11

Gene therapy with adeno-associated virus vector 5-human factor IX in adults with hemophilia B.
Wolfgang Miesbach, Karina Meijer, Michiel Coppens, Peter Kampmann, Robert Klamroth, Roger Schutgens, Marco Tangelder, Giancarlo Castaman, Joachim Schwäble, Halvard Bonig,[...]. Blood 2018
153
11



Long-term expression of human coagulation factor VIII and correction of hemophilia A after in vivo retroviral gene transfer in factor VIII-deficient mice.
T VandenDriessche, V Vanslembrouck, I Goovaerts, H Zwinnen, M L Vanderhaeghen, D Collen, M K Chuah. Proc Natl Acad Sci U S A 1999
143
10


Purified human factor VIII procoagulant protein: comparative hemostatic response after infusions into hemophilic and von Willebrand disease dogs.
K M Brinkhous, H Sandberg, J B Garris, C Mattsson, M Palm, T Griggs, M S Read. Proc Natl Acad Sci U S A 1985
161
10

Antigenicity of putative phospholipid membrane-binding residues in factor VIII.
R T Barrow, J F Healey, M G Jacquemin, J M Saint-Remy, P Lollar. Blood 2001
60
16

Induction of immune tolerance to coagulation factor IX antigen by in vivo hepatic gene transfer.
Federico Mingozzi, Yi-Lin Liu, Eric Dobrzynski, Antje Kaufhold, Jian Hua Liu, YuQin Wang, Valder R Arruda, Katherine A High, Roland W Herzog. J Clin Invest 2003
351
10

The tertiary structure and domain organization of coagulation factor VIII.
Betty W Shen, Paul Clint Spiegel, Chong-Hwan Chang, Jae-Wook Huh, Jung-Sik Lee, Jeanman Kim, Young-Ho Kim, Barry L Stoddard. Blood 2008
168
10

Eradication of neutralizing antibodies to factor VIII in canine hemophilia A after liver gene therapy.
Jonathan D Finn, Margareth C Ozelo, Denise E Sabatino, Helen W G Franck, Elizabeth P Merricks, Julie M Crudele, Shangzhen Zhou, Haig H Kazazian, David Lillicrap, Timothy C Nichols,[...]. Blood 2010
111
10

The efficacy and the risk of immunogenicity of FIX Padua (R338L) in hemophilia B dogs treated by AAV muscle gene therapy.
Jonathan D Finn, Timothy C Nichols, Nikolaos Svoronos, Elizabeth P Merricks, Dwight A Bellenger, Shangshen Zhou, Paolo Simioni, Katherine A High, Valder R Arruda. Blood 2012
75
13


Residues Glu2181-Val2243 contain a major determinant of the inhibitory epitope in the C2 domain of human factor VIII.
J F Healey, R T Barrow, H M Tamim, I M Lubin, M Shima, D Scandella, P Lollar. Blood 1998
83
10

Human recombinant DNA-derived antihemophilic factor (factor VIII) in the treatment of hemophilia A. recombinant Factor VIII Study Group.
R S Schwartz, C F Abildgaard, L M Aledort, S Arkin, A L Bloom, H H Brackmann, D B Brettler, H Fukui, M W Hilgartner, M J Inwood. N Engl J Med 1990
211
9



Bioengineering of coagulation factor VIII for improved secretion.
Hongzhi Z Miao, Nongnuch Sirachainan, Lisa Palmer, Phillip Kucab, Michael A Cunningham, Randal J Kaufman, Steven W Pipe. Blood 2004
147
9


Minimal modification in the factor VIII B-domain sequence ameliorates the murine hemophilia A phenotype.
Joshua I Siner, Nicholas P Iacobelli, Denise E Sabatino, Lacramiora Ivanciu, Shangzhen Zhou, Mortimer Poncz, Rodney M Camire, Valder R Arruda. Blood 2013
53
16

Employing a gain-of-function factor IX variant R338L to advance the efficacy and safety of hemophilia B human gene therapy: preclinical evaluation supporting an ongoing adeno-associated virus clinical trial.
Paul E Monahan, Junjiang Sun, Tong Gui, Genlin Hu, William B Hannah, David G Wichlan, Zhijian Wu, Joshua C Grieger, Chengwen Li, Thipparat Suwanmanee,[...]. Hum Gene Ther 2015
74
12

Platelet-targeted gene therapy with human factor VIII establishes haemostasis in dogs with haemophilia A.
Lily M Du, Paquita Nurden, Alan T Nurden, Timothy C Nichols, Dwight A Bellinger, Eric S Jensen, Sandra L Haberichter, Elizabeth Merricks, Robin A Raymer, Juan Fang,[...]. Nat Commun 2013
77
11

Emicizumab Prophylaxis in Hemophilia A with Inhibitors.
Johannes Oldenburg, Johnny N Mahlangu, Benjamin Kim, Christophe Schmitt, Michael U Callaghan, Guy Young, Elena Santagostino, Rebecca Kruse-Jarres, Claude Negrier, Craig Kessler,[...]. N Engl J Med 2017
466
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.